Mechanisms Underlying Vascular Endothelial Growth Factor Receptor Inhibition-Induced Hypertension: The HYPAZ Trial. (2021)
Attributed to:
Cambridge Mathematics of Information in Healthcare (CMIH)
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.65323
Publication URI: https://www.repository.cam.ac.uk/handle/1810/318206
Type: Journal Article/Review